RespireRx Pharmaceuticals Inc (fka RSPI)

[Aiming4]

Neuro - I trust your impressions since you've met Coleman and I'm glad to hear that the purchase he just made carries more weight than I would have guessed.

From his bio, I would have guessed that he has done very well financially... that is unless he's a unreformed bio-gambler, as Gfp has aptly labeled most of us here. :^)

James H. Coleman

Senior Vice President, Business Development

Mr. Coleman became Senior Vice President of Business Development in May 2000. Prior to joining Cortex, Mr. Coleman was President and Managing Partner of Diversified Healthcare Management, LLC (DHM), a biopharmaceutical consulting firm that he founded in 1997 in Irvine, CA. Cortex was a client of DHM for the year prior to his joining the company. Mr. Coleman brings to Cortex over 30 years of combined CNS pharmaceutical and biopharmaceutical experience at The Upjohn Company, Pharmacia & Upjohn, Inc., and CoCensys where he acquired extensive management and operational expertise in corporate partnering, global strategic CNS marketing, clinical psychopharmacological research and sales. Mr. Coleman, designed and managed the worldwide panic disorder research program that resulted in the first FDA and other offshore regulatory approvals that established Xanax® as the standard treatment for panic disorder. Mr. Coleman holds a B.S. degree in Applied Biology from the University of Rhode Island.